- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02545816
Comparing Simplified EEG Monitoring Tool With Standard EEG Monitoring in Patients With Acute Neurological Insult
March 24, 2018 updated by: prof. dr. Frank Jans, Hasselt University
A Validation Study to Compare Bispectral Index EEG Monitoring With Full EEG in Patients With an Acute Neurological Insult
After any acute brain injury, a primary pathophysiological response arises, enabling the brain to develop seizures and/or a status epilepticus (SE).
These are frequently reported in patients admitted to the intensive care unit (ICU) with traumatic brain injury and brain injury caused by subarachnoid or intracerebral hemorrhage.
Seizures can be presented without any clinical motor signs, which are then termed as nonconvulsive, and therefore remain frequently clinically unrecognized.
As such, it is of great importance that these patients are diagnosed as early as possible since the increased metabolic demand and blood flow associated with an epileptic insult may further compromise the brain at risk.
Thus far, continuous EEG (cEEG) is the only clinical instrument that is able to detect the development of early epileptic activity.
Unfortunately, cEEG is not available in most ICUs and is labor-intensive, expensive and difficult to interpret for non-trained physicians.
Therefore, a more simple and prognostic accurate EEG device is highly warranted to detect seizures in an early stage so that patients might benefit from a specific and early treatment.
A validation study in comatose patients with an acute neurological insult will be conducted to provide evidence that simplified Bispectral Index EEG monitoring has the potential to detect epileptic activity as reliable as its gold standard, full EEG monitoring.
Thereby, BIS EEG monitoring could possibly be used to facilitate the prognostication and management of epileptic seizures in this patient cohort which could eventually improve the clinical outcome.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ward Eertmans, drs.
- Email: frank.jans@uhasselt.be
Study Contact Backup
- Name: Frank Jans, prof. dr.
- Email: frank.jans@zol.be
Study Locations
-
-
-
Genk, Belgium, 3830
- Recruiting
- Ziekenhuis Oost-Limburg
-
Contact:
- Ward Eertmans, drs.
- Email: ward.eertmans@uhasselt.be
-
Principal Investigator:
- Frank Jans, prof. dr.
-
Sub-Investigator:
- Ward Eertmans, drs
-
Sub-Investigator:
- Cathy De Deyne, prof. dr.
-
Sub-Investigator:
- Pascal Vanelderen, prof. dr.
-
Sub-Investigator:
- Willem Boer, dr.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients (age ≥ 18 years) admitted to the ICU with an acute neurological insult which will be sedated/ventilated (Glasgow Coma Scale (GCS) ≤ 8).
- Ability to place BIS sensors on the forehead
- Written informed consent form has to be obtained from the patient's next of kin and has to be reconfirmed if the patient regains consciousness
Exclusion Criteria:
- Age < 18 years
- Inability to place BIS sensors on the forehead (e.g. due to frontal decompression)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: study group
Patients (age ≥ 18 years) admitted to the ICU with an acute neurological insult which will be sedated/ventilated (Glasgow Coma Scale (GCS) ≤ 8).
|
The Bispectral Index (BIS) EEG monitor is a simplified EEG monitoring device which was originally designed to monitor the depth of hypnosis during general anesthesia.
It does this by analyzing changes in the processed electroencephalogram (EEG) which occur with the hypnotic state and creating a measure (or index) indicative of these changes.
A number between 0 and 100 is derived, with values above 70 associated with an awake state.
The monitor also provides a single channel EEG, an electromyogram (EMG) and an index of signal quality (SQI), all in real time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
A comparison between BIS derived EEG and standard full EEG
Time Frame: 15 minutes before or after the acquisition of standard full EEG monitoring.
|
Unfiltered BIS derived EEG data from 15 minutes before or after the acquisition of a full intermittent EEG will be used to compare BIS derived EEG traces with full intermittent EEG traces.
These data will be (retrospectively) analyzed by experienced neurophysiologists for the presence of seizures and/or status epilepticus.
|
15 minutes before or after the acquisition of standard full EEG monitoring.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Frank Jans, prof. dr., Ziekenhuis Oost-Limburg, Hasselt University
- Study Chair: Cathy De Deyne, prof. dr., Ziekenhuis Oost-Limburg, Hasselt University
- Study Chair: Willem Boer, dr., Ziekenhuis Oost-Limburg
- Study Chair: Pascal Vanelderen, prof. dr, Ziekenhuis Oost-Limburg, Hasselt University
- Study Chair: Ward Eertmans, drs., Hasselt University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Anticipated)
May 1, 2018
Study Completion (Anticipated)
May 1, 2018
Study Registration Dates
First Submitted
August 20, 2015
First Submitted That Met QC Criteria
September 8, 2015
First Posted (Estimate)
September 10, 2015
Study Record Updates
Last Update Posted (Actual)
March 27, 2018
Last Update Submitted That Met QC Criteria
March 24, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- BISZOL1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Neurological Insult
-
Sohag UniversityRecruiting
-
Massachusetts General HospitalRecruitingEmotional Distress | Acute Neurological InjuryUnited States
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Washington University School of MedicineAstellas Pharma IncCompletedThis Study is to Understand the Current Practice of Sodium Management in Acute Neurological InjuryUnited States
-
Centre Hospitalier Universitaire de la RéunionRecruitingNeurological ComplicationRéunion
-
RWTH Aachen UniversityCompletedNeurological OutcomeGermany
-
BDH-Klinik Hessisch OldendorfRecruitingNeurological RehabilitationGermany
-
The University of Texas Health Science Center,...Recruiting
-
Hospices Civils de LyonActive, not recruitingNeurological Diseases or Conditions | Neurological Diseases Associated to Anti GFAP AntibodiesFrance
-
Lady Davis InstituteKripalu Institute and the Mind and Life InstituteCompleted
Clinical Trials on Bispectral index (BIS) EEG monitoring
-
Hopital FochWithdrawn
-
Istanbul Medeniyet UniversityUnknown
-
Mansoura UniversityCompletedLiver CirrhosisEgypt
-
Mayo ClinicCompletedAnesthesia | Bispectral Index | Cardiovascular SurgeryUnited States
-
Rajiv Gandhi Cancer Institute & Research Center...Unknown
-
Duke UniversityMedtronic - MITG; University of North CarolinaTerminated
-
Rabin Medical CenterActive, not recruiting
-
Baystate Medical CenterTerminatedTachycardia, VentricularUnited States
-
Capital Medical UniversityCompletedBrain Injuries | Intensive CareChina